ACR Share Price

Open 0.32 Change Price %
High 0.32 1 Day 0.00 0.00
Low 0.32 1 Week 0.00 0.00
Close 0.32 1 Month 0.00 0.00
Volume 179279 1 Year -0.36 -52.94
52 Week High 0.83
52 Week Low 0.31
ACR Important Levels
Resistance 2 0.32
Resistance 1 0.32
Pivot 0.32
Support 1 0.32
Support 2 0.32
ASX Australia Most Active Stocks
AKK 0.01 0.00%
GPP 0.03 0.00%
IMU 0.01 0.00%
IMU 0.01 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
BUR 0.02 0.00%
TEG 0.00 -100.00%
TEG 0.00 -100.00%
TEG 0.00 -100.00%
More..
ASX Australia Top Gainers Stocks
KSO 0.40 3900.00%
AHN 0.04 100.00%
AZS 0.03 50.00%
AZS 0.03 50.00%
PMQ 0.03 50.00%
NGY 0.05 25.00%
BIT 0.05 25.00%
BIT 0.05 25.00%
RAW 0.06 20.00%
RAW 0.06 20.00%
More..
ASX Australia Top Losers Stocks
TEG 0.00 -100.00%
TEG 0.00 -100.00%
TEG 0.00 -100.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
APP 0.20 -80.00%
TCQ 0.27 -73.53%
BMN 0.02 -33.33%
AZM 0.03 -25.00%
More..

Acrux Ltd (ASX: ACR)

ACR Technical Analysis 5
As on 5th Dec 2016 ACR Share Price closed @ 0.32 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.58 & Strong Sell for SHORT-TERM with Stoploss of 0.34 we also expect STOCK to react on Following IMPORTANT LEVELS.
ACR Target for December
1st Target up-side 0.34
2nd Target up-side 0.36
3rd Target up-side 0.37
1st Target down-side 0.3
2nd Target down-side 0.28
3rd Target down-side 0.27
ACR Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.acrux.com.au
ACR Address
ACR
103-113 Stanley Street
West Melbourne, VIC 3003
Australia
Phone: 61 3 8379 0100
Fax: 61 3 8379 0101
ACR Latest News
Interactive Technical Analysis Chart Acrux Ltd ( ACR ASX Australia )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Acrux Ltd
ACR Business Profile
Acrux Limited, a drug delivery company, develops and commercializes a range of patient-preferred and patented pharmaceutical products using its technology to administer proven medicines through the skin. The company’s products include Axiron to treat testosterone deficiency in men; Evamist for menopause symptoms; and Recuvyra pain relief for dogs. Its product under registration comprises Estradiol MDTS for menopause symptoms. The company is also developing Luramist for female HSDD; Nestorone MDTS for contraception; Nicotine MDTS for smoking cessation; and NSAIDs for pain and inflammation. It operates in Australia, accessing international pharmaceutical markets through commercial partners. Acrux was founded in 1998 and is based in West Melbourne, Australia.